The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value – an Evaluation of Rosuvastatin therapY compared with atorvastatin

Author： Fonseca Francisco A. H.   Ruiz Alvaro   Cardona-Muñoz Ernesto G.   Silva Jose M.   Fuenmayor Nery   Marotti Marcelo  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.8, 2005-08, pp. : 1307-1316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

By Athyros Vasilios G.   Mikhailidis Dimitri P.   Papageorgiou Athanasios A.   Symeonidis Athanasios N.   Daskalopoulou Stella S.   Kakafika Anna I.   Pehlivanidis Anthimos N.   Bouloukos Vasilios I.   Langer Anatoly    

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1385-1392

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice

By Gandhi Sanjay K.   Järbrink Krister   Fox Kathleen M.   Brandrup-Wognsen Gunnar  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2817-2828

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States

By Fox Kathleen M.   Gandhi Sanjay K.   Ohsfeldt Robert L.   Blasetto James W.   Bays Harold E.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2125-2133

Informa Healthcare

Access to resources Recommend Favorite

LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study

By Jukema J. Wouter   Liem An-Ho   Dunselman Peter H. J. M.   van der Sloot Jos A. P.   Lok Dirk J. A.   Zwinderman Aeilko H.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1865-1874

Informa Healthcare

Access to resources Recommend Favorite

A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study

By Farsang C.   Athyros V.   Gaw A.    

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1945-1956

Informa Healthcare

Access to resources Recommend Favorite